Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fed Conditions

This study has been completed.
Information provided by (Responsible Party):
Ranbaxy Inc. Identifier:
First received: August 13, 2012
Last updated: NA
Last verified: August 2012
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)